Header Logo

Connection

PAOLO ANDERLINI to Antigens, Differentiation, Myelomonocytic

Back to Details
This is a "connection" page, showing publications PAOLO ANDERLINI has written about Antigens, Differentiation, Myelomonocytic.
PAOLO ANDERLINI
Connection Strength
0.018
Antigens, Differentiation, Myelomonocytic
  1. Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome. Leukemia. 2008 Feb; 22(2):258-64.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.